1. Home
  2. ORIC vs CLBR Comparison

ORIC vs CLBR Comparison

Compare ORIC & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • CLBR
  • Stock Information
  • Founded
  • ORIC 2014
  • CLBR 2023
  • Country
  • ORIC United States
  • CLBR United States
  • Employees
  • ORIC N/A
  • CLBR N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • CLBR
  • Sector
  • ORIC Health Care
  • CLBR
  • Exchange
  • ORIC Nasdaq
  • CLBR Nasdaq
  • Market Cap
  • ORIC 362.9M
  • CLBR 304.5M
  • IPO Year
  • ORIC 2020
  • CLBR 2023
  • Fundamental
  • Price
  • ORIC $11.10
  • CLBR $16.30
  • Analyst Decision
  • ORIC Strong Buy
  • CLBR
  • Analyst Count
  • ORIC 9
  • CLBR 0
  • Target Price
  • ORIC $18.29
  • CLBR N/A
  • AVG Volume (30 Days)
  • ORIC 949.2K
  • CLBR 1.4M
  • Earning Date
  • ORIC 08-11-2025
  • CLBR 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • CLBR N/A
  • EPS Growth
  • ORIC N/A
  • CLBR N/A
  • EPS
  • ORIC N/A
  • CLBR 0.19
  • Revenue
  • ORIC N/A
  • CLBR N/A
  • Revenue This Year
  • ORIC N/A
  • CLBR N/A
  • Revenue Next Year
  • ORIC N/A
  • CLBR N/A
  • P/E Ratio
  • ORIC N/A
  • CLBR $84.23
  • Revenue Growth
  • ORIC N/A
  • CLBR N/A
  • 52 Week Low
  • ORIC $3.90
  • CLBR $10.15
  • 52 Week High
  • ORIC $14.67
  • CLBR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • CLBR 61.08
  • Support Level
  • ORIC $10.42
  • CLBR $14.90
  • Resistance Level
  • ORIC $11.50
  • CLBR $17.43
  • Average True Range (ATR)
  • ORIC 0.62
  • CLBR 1.38
  • MACD
  • ORIC -0.03
  • CLBR 0.12
  • Stochastic Oscillator
  • ORIC 83.30
  • CLBR 75.72

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About CLBR Colombier Acquisition Corp. II

Colombier Acquisition Corp II is a blank check company.

Share on Social Networks: